Your browser doesn't support javascript.
loading
The proteome of clear cell ovarian carcinoma.
Ji, Jennifer X; Cochrane, Dawn R; Negri, Gian Luca; Colborne, Shane; Spencer Miko, Sandra E; Hoang, Lynn N; Farnell, David; Tessier-Cloutier, Basile; Huvila, Jutta; Thompson, Emily; Leung, Samuel; Chiu, Derek; Chow, Christine; Ta, Monica; Köbel, Martin; Feil, Lucas; Anglesio, Michael; Goode, Ellen L; Bolton, Kelly; Morin, Gregg B; Huntsman, David G.
Affiliation
  • Ji JX; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Cochrane DR; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada.
  • Negri GL; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Colborne S; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Spencer Miko SE; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Hoang LN; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Farnell D; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Tessier-Cloutier B; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Huvila J; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada.
  • Thompson E; Department of Biomedicine, University of Turku, Turku, Finland.
  • Leung S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Chiu D; Genetic Pathology Evaluation Center, Vancouver, BC, Canada.
  • Chow C; Genetic Pathology Evaluation Center, Vancouver, BC, Canada.
  • Ta M; Genetic Pathology Evaluation Center, Vancouver, BC, Canada.
  • Köbel M; Genetic Pathology Evaluation Center, Vancouver, BC, Canada.
  • Feil L; Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.
  • Anglesio M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Goode EL; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Bolton K; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
  • Morin GB; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Huntsman DG; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.
J Pathol ; 258(4): 325-338, 2022 12.
Article in En | MEDLINE | ID: mdl-36031730
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Adenocarcinoma, Clear Cell Limits: Female / Humans Language: En Journal: J Pathol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Adenocarcinoma, Clear Cell Limits: Female / Humans Language: En Journal: J Pathol Year: 2022 Document type: Article Affiliation country: Country of publication: